Atlas Trials

Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age

Clinical trial NCT03025750 · COMPLETED

Trial details

NCT number
NCT03025750
Sponsor
Statens Serum Institut
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Poliomyelitis
Start date
2017-01-19
Primary completion
2017-11-14
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.